Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia Post author: Post published:March 1, 2026 Post category: Continue ReadingAutologous Muscle Derived Cells for Treatment of Tongue Dysphagia
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma Post author: Post published:March 1, 2026 Post category: Continue ReadingIntracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS) Post author: Post published:March 1, 2026 Post category: Continue ReadingA Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)
Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells Post author: Post published:March 1, 2026 Post category: Continue ReadingAnti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS Post author: Post published:March 1, 2026 Post category: Continue ReadingCNS10-NPC-GDNF Delivered to the Motor Cortex for ALS
Phase 1/2a Study of ANPD001 in Parkinson Disease Post author: Post published:March 1, 2026 Post category: Continue ReadingPhase 1/2a Study of ANPD001 in Parkinson Disease
Continued Evaluation of Patients With Parkinson’s Disease Who Previously Received BRT-DA01 Post author: Post published:March 1, 2026 Post category: Continue ReadingContinued Evaluation of Patients With Parkinson’s Disease Who Previously Received BRT-DA01
